Michael Kaseta

CIK 1724346 · CFO and COO · last filed 2026-04-16

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$29.14M

Companies

4

Total Filings

49

Lifetime Open-Market Net

-$16.74M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LQDA CFO and COO 408,775 $71.23 $29.12M -$16.74M 40 2026-04-16
HRTX Director 53,960 $0.40 $21.6K $0 4 2026-02-03
ALIMERA SCIENCES INC (ALIM) Delisted Director $5.54 $0 2 2023-10-04
Aralez Pharmaceuticals Inc. (ARLZ) Delisted Chief Financial Officer 15,000 $0 2 2018-03-19

Recent Filings · Page 5 of 5

49 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-08-01 LQDA Grant (A) $0 EDGAR
2022-06-01 LQDA Buy (P) +18,700 $74.9K EDGAR
2022-01-19 LQDA Grant (A) $0 EDGAR
2021-11-12 LQDA Mixed +9,250 $0 EDGAR
2021-07-23 LQDA Grant (A) $0 EDGAR
2021-01-20 LQDA Grant (A) $0 EDGAR
2020-12-01 LQDA Grant (A) $0 EDGAR
2018-03-19 Aralez Pharmaceuticals Inc. (ARLZ) Delisted Grant (A) +12,500 $0 EDGAR
2017-12-04 Aralez Pharmaceuticals Inc. (ARLZ) Delisted Grant (A) $0 EDGAR
Showing 4149 of 49
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.